"A year and a half later, [the job] was reopened, and they're hiring real people again. I guess it didn't work out with AI." ...
The gene therapy uses an AAV vector to restore healthy levels of the alpha-galactosidase enzyme, which is rendered dysfunctional in patients with Fabry disease, leading to the toxic build-up of lipids ...
If you've followed Edmund McMillen at all in the past, oh, decade, then you've probably heard of Mewgenics at least in ...
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its Phase 1/2 PIONEER-ALS trial evaluating ...
AI has steadily woven itself into every corner of security, its influence is only beginning to take shape. Identity is expanding beyond people, compliance is becoming part of everyday defense, and the ...
'Claude DXT's container falls noticeably short of what is expected from a sandbox' LayerX, a security company based in Tel Aviv, says it has identified a zero-click remote code execution vulnerability ...
"A year and a half later, [the job] was reopened, and they're hiring real people again. I guess it didn't work out with AI." ...
Over the past year, China's rising cultural influence has become a talking point. It began with Ne Zha 2. The animated blockbuster, rooted in Chinese mythology, didn't just perform well — within 45 ...
There’s a Chinese expression—zuò shan guan hǔ dòu—which roughly translates to “Sit on the mountain and watch tigers fight.” ...
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...
The argument for AI-powered document review is all but over. Large language models are smarter, faster, more consistent, and less expensive than ...
Leaked non-human identities like API keys and tokens are becoming a major breach driver in cloud environments. Flare shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results